Contract Pharma Manufacturing Webinars
-
The Nature Of Quality Management Needs To Change
10/24/2023
In these 3 minutes, Bikash Chatterjee, an Outsourced Pharma Board Member, discusses how the current drug development and manufacturing landscape necessitates different approaches for quality teams.
-
The Wrong Way For Your CDMO To Upgrade Facilities
10/24/2023
Christine Feaster, who has worked for top 50 pharma and start-up organizations, relates a case study as a warning to sponsors when CDMOs look to upgrade facilities and add capabilities.
-
Today’s Quality And Regulatory Workforce Challenges
10/24/2023
Erin O'Brien (Biogen), Christine Feaster (QxP), and Bikash Chatterjee (Pharmactech Associates) discuss new workforce realities and tactics at sponsors and CDMOs that followed the "great resignation."
-
Quality Agreements, Inspections, And PQS
10/24/2023
Karla Knower of Paradigm Biopharmaceuticals informs Outsourced Pharma Live attendees about quality agreements, inspections, and implementing a Pharmaceutical Quality System (PQS).
-
Accelerated Approval Pressures Starting Materials
10/24/2023
Our panel of outsourcing experts discuss the need for speed in today’s development of drugs and therapies, and how that impacts the quest for and maintenance of quality starting materials.
-
The Outsourcing Context Has Changed. Have You?
10/24/2023
Bikash Chatterjee, Pharmatech Associates explains how the scope of quality, regulatory, technical, and CMC development professional has changed dramatically.
-
Managing Multiple Partners – And Materials – From Around The Globe
10/24/2023
Two development and manufacturing outsourcing professionals – one based in Australia and one the east coast of the U.S. – begin our discussion on global outsourcing.
-
Workforce Challenges Key To Outsourcing
10/24/2023
Christine Feaster of QxP Consulting starts our discussion by focusing on a key to various realms of outsourcing: today’s workforce.
-
Viral Vector Manufacturing: Improve Efficiency With A Platform Approach
9/25/2023
Learn more about the platform-based scalable suspension process for LVV production and how it is impacting CGTs advancing toward commercialization.
-
Don't Skip Preformulation: Your Blueprint For Drug Development Success
9/22/2023
Investing in the right preformulation studies and gathering evidence to inform decisions is critical to identify product dead-ends and failure modes without the pain of hindsight.